Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
HCI Group
HCI
$2.29B
| $585K | ﹤0.01% |
11,858
+5,378
| +83% | +$273K |
|
3077
CALL
OraSure Technologies
OSUR
$265M
| $585K | ﹤0.01% |
+48,100
| New | +$657K |
|
3078
Applied Optoelectronics
AAOI
$12.7B
| $584K | ﹤0.01% |
51,894
+3,429
| +7% | +$41.5K |
|
3079
PUT
BlackBerry
BB
$5.22B
| $584K | ﹤0.01% |
127,200
| – | – |
|
|
CSW
3080
CSW Industrials
CSW
$5.62B
| $584K | ﹤0.01% |
7,574
-4,349
| -36% | -$315K |
|
|
INFN
3081
DELISTED
Infinera Corporation Common Stock
INFN
| $583K | ﹤0.01% |
94,634
-16,767
| -15% | -$117K |
|
3082
CALL
Inovio Pharmaceuticals
INO
$113M
| $580K | ﹤0.01% |
4,167
+3,334
| +400% | +$695K |
|
3083
CALL
Moody's
MCO
$84B
| $580K | ﹤0.01% |
2,000
| – | – |
|
|
3084
PUT
Moody's
MCO
$84B
| $580K | ﹤0.01% |
2,000
-1,900
| -49% | -$542K |
|
3085
Nordic American Tanker
NAT
$1.42B
| $580K | ﹤0.01% |
166,283
+84,403
| +103% | +$352K |
|
3086
Restaurant Brands International
QSR
$27.1B
| $579K | ﹤0.01% |
10,078
-38,622
| -79% | -$2.15M |
|
3087
The RealReal
REAL
$1.39B
| $579K | ﹤0.01% |
39,893
+39,861
| +124,566% | +$609K |
|
3088
CALL
Eastman Chemical
EMN
$8.47B
| $578K | ﹤0.01% |
7,400
| – | – |
|
3089
American Vanguard Corp
AVD
$62.5M
| $577K | ﹤0.01% |
43,875
+7,904
| +22% | +$110K |
|
3090
Core Laboratories
CLB
$571M
| $577K | ﹤0.01% |
37,759
+16,834
| +80% | +$353K |
|
3091
CALL
Dillards
DDS
$8.76B
| $577K | ﹤0.01% |
15,800
| – | – |
|
3092
CALL
Eli Lilly
LLY
$1.05T
| $577K | ﹤0.01% |
3,900
-31,500
| -89% | -$4.88M |
|
3093
Columbus McKinnon
CMCO
$556M
| $576K | ﹤0.01% |
17,412
-2,456
| -12% | -$85.2K |
|
3094
Galicia Financial Group
GGAL
$6.97B
| $576K | ﹤0.01% |
79,408
+24,642
| +45% | +$258K |
|
3095
PUT
GSK
GSK
$99.2B
| $576K | ﹤0.01% |
12,240
| – | – |
|
|
ZEN
3096
PUT
DELISTED
ZENDESK INC
ZEN
| $576K | ﹤0.01% |
5,600
-1,100
| -16% | -$103K |
|
3097
Myers Industries
MYE
$1.24B
| $575K | ﹤0.01% |
43,496
+10,658
| +32% | +$159K |
|
3098
Covenant Logistics
CVLG
$886M
| $573K | ﹤0.01% |
66,474
-21,638
| -25% | -$188K |
|
|
GOOD
3099
Gladstone Commercial Corp
GOOD
$626M
| $573K | ﹤0.01% |
34,044
-6,013
| -15% | -$110K |
|
3100
Agilysys
AGYS
$3.22B
| $572K | ﹤0.01% |
23,667
+5,883
| +33% | +$131K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.